Home About Products & Services News Research Investors Contact


Patients and Caregivers

NeuroStar TMS Therapy is the first and only TMS Therapy® device that has been proven to be effective and safe in the treatment of depressed patients who have not received adequate benefit from prior antidepressant medication treatment. As a result, it is the first and only FDA-cleared TMS Therapy device for this use. If you are interested in learning about where treatment with NeuroStar TMS Therapy is available or if you have questions, please provide us your contact information and a Neuronetics customer service representative will contact you shortly.The information you provide to us is subject to the Neuronetics Privacy Policy.

Customer Service Center: 1-877-600-7555

Name: *
Company or Institution:
Address: *
City: *
State: *
Zip: *
Other:
Country: *
Other:
Zip Code:
Phone is the quickest method
for us to reach you.
Phone:
Email:
Are you a patient or a caregiver?
 
How did you hear about TMS Therapy?
 
How did you hear about Neuronetics?
 
Inquiry (check all that apply):
Find a doctor that provides TMS Therapy
Medical Information/Questions
Other:
 
Other Comments:

By checking this box you allow Neuronetics to share your supplied
contact information with TMS Therapy providers in your area.



* Required Field
NeuroStar TMS Therapy® is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode. Click here for full prescribing and safety information

This link provides you with access to recent published information and news about NeuroStar TMS Therapy and new options for the treatment of depression. Neuronetics does not provide any assurances of the accuracy of this information and may not agree with the opinions of the authors.

NeuroStar TMS Therapy is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode. To return to the Neuronetics website for full safety and prescribing information click here.

Click here to continue.